Related Experiment Video
Updated: Jun 15, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Involvement of apoptosis in mediating mitomycin C-induced teratogenesis in vitro
Gyanendra Singh1, Neeraj Sinha
1Division of Toxicology, Central Drug Research Institute, Lucknow 226001, India. gyancdri@gmail.com
Abstract:
Mitomycin C (MMC) is among the most commonly used drugs worldwide and is known to cause congenital malformations and fetal death in animals. In this study, the effect of MMC on major organogenesis period and the role of apoptosis in mediating congenital malformations have been carried out. In the present study, post-implantation rat embryos of day 11 were cultured for 24 h with various concentrations of MMC, i.e. 1, 10, and 100 microg/ml cultures. The growth and developmental of each embryo was evaluated and compared with control ones for the presence of any malformations. The MMC decreased all growth and developmental parameters in a concentration-dependent manner, when compared with control. However, exposure to MMC at 1 microg/ml culture did not show any significant effect on embryonic growth and development. Parallel to this, flow cytometric analysis (cell cycle and annexin V binding) and DNA fragmentation assay were carried out followed by quantitation by 3'-OH labeling of cultured rat embryos to evaluate the role of apoptosis in bringing about MMC-induced teratogenesis. All results were found to be dose-dependent and an increase in apoptosis in embryonic tissues may be related to the increased risk of congenital malformations. The data suggested that apoptosis might be involved in mediating teratogenesis of MMC in vitro.
Insights
Mitomycin C (MMC) can cause birth defects. This study shows MMC increases apoptosis, a cell death process, in developing rat embryos, suggesting it may mediate these congenital malformations.
Area of Science:
- Developmental Biology
- Toxicology
- Cell Biology
Background:
- Mitomycin C (MMC) is a widely used drug with known teratogenic effects in animal models.
- Congenital malformations and fetal death are significant concerns associated with MMC exposure.
- The precise mechanisms underlying MMC-induced teratogenesis, particularly the role of apoptosis, require further elucidation.
Purpose of the Study:
- To investigate the impact of Mitomycin C on embryonic development during the critical organogenesis period.
- To determine the role of apoptosis in mediating Mitomycin C-induced congenital malformations in vitro.
- To establish a dose-dependent relationship between MMC exposure, apoptosis, and teratogenic outcomes.
Main Methods:
- Post-implantation rat embryos (day 11) were cultured in vitro with varying concentrations of Mitomycin C (1, 10, 100 microg/ml).
- Embryonic growth and development were assessed and compared to control groups.
- Apoptosis was evaluated using flow cytometry (cell cycle, annexin V binding) and DNA fragmentation assays, including 3'-OH labeling.
Main Results:
- Mitomycin C exposure significantly inhibited embryonic growth and development in a dose-dependent manner.
- A concentration of 1 microg/ml MMC did not produce significant adverse effects on embryonic parameters.
- Increased apoptosis was observed in embryonic tissues following MMC exposure, correlating with teratogenic effects.
Conclusions:
- Mitomycin C exerts dose-dependent inhibitory effects on embryonic growth and development in vitro.
- Apoptosis plays a significant role in mediating Mitomycin C-induced teratogenesis.
- These findings highlight the potential risks of Mitomycin C during pregnancy and underscore the involvement of programmed cell death in drug-induced developmental toxicity.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:42Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Related Concept Videos
Mutagenicity and Carcinogenicity
Cellular Injury V: Apoptosis and Autophagy
In vitro Mutagenesis
Teratogenicity
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules